By modulating these mechanisms, we can develop therapeutic strategies that enhance the sensitivity of tumor cells to radiation while mitigating radiation-induced damage to normal brain tissues, thereby improving the overall outcomes of radiotherapy
Articles connexes Reta Peptide (Retatrutide) : Triple Agoniste -24,2% Donnes 2026 Le reta peptide (retatrutide) est le triple agoniste GLP-1/GIP/glucagon le plus document
But the potential is very exciting
Lets break down what it is, how it works, and what the research really says about its effects on these stubborn injuries
Iwaya, C., Nomiyama, T., Komatsu, S., Kawanami, T., Tsutsumi, Y., Hamaguchi, Y., Horikawa, T., Yoshinaga, Y., Yamashita, S., Tanaka, T., et al